Wednesday, October 4, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from Vifor Pharma
Steering Committee Chair
Professor, Institute of Health Innovations & Outcomes Research, Feinstein Institutes for Medical Research
Chief of Nephrology, , Division of Kidney Disease and Hypertension, Northwell Health
Vice President, Northwell Health for Network Dialysis Services, Northwell Health
Professor, Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Manhasset, New York
Steering Committee Member
Nephrology, Renal and Transplant Associates of New England
Professor of Medicine Tufts School of Medicine
Springfield, Massachusetts
Steering Committee Member
Professor of Medicine, School of Medicine
Chief, Division of Nephrology, Hypertension and Kidney Transplantation
University of California, Irvine
Adjunct Professor of Epidemiology, UCLA Fielding School of Public Health
Irvine, California
Steering Committee Member
Professor of Clinical Medicine, Nephrology
University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania
Steering Committee Member
Professor and Clinical Chief of Nephrology
Director of Nephrology Clinical Research Program, Medical Director of the ESRD | Dialysis Program, and Living Kidney Donor Program
David Geffen School of Medicine at UCLA
Los Angeles, California
Steering Committee Member
Professor and Clinical Chief of Nephrology
Assistant Professor of Medicine in the Division of Nephrology, Columbia University Irving Medical Center
New York, New York
Has the following relevant financial relationships:
Served as an advisor or consultant for: Cara Therapeutics; Vifor Pharma
Has the following relevant financial relationships:
Served as an advisor or consultant for: Cara Therapeutics; Vifor Pharma
Served as a speaker or a member of a speakers bureau for: Cara Therapeutics; Vifor Pharma
Received grants for clinical research from: Cara Therapeutics
Has the following relevant financial relationships:
Served as an advisor or consultant for: Abbott; AbbVie, Inc.; ACI Clinical (Cara Therapeutics); Akebia Therapeutics; Alexion Pharmaceuticals, Inc.; Amgen; Ardelyx; AstraZeneca; AVEO Pharmaceuticals, Inc.; B.Braun; Chugai Pharma; Cytokinetics; Daiichi Sankyo; DaVita; Fresenius Medical Care North America (FMC-NA); Genentech, Inc.; GlaxoSmithKline; Haymarket Media; Hospira; Fresenius Kabi; Keryx Biopharmaceuticals; Kissei, Novartis, Novo-Nordisk, OPKO Health; Pfizer, Regulus Therapeutics; Relypsa; Resverlogix; Dr Schaer; Sandoz; Sanofi; Shire; Takeda; Vifor; ZS Pharma
Served as a speaker or a member of a speakers bureau for: Abbott; AbbVie, Inc.; ACI Clinical (Cara Therapeutics); Akebia Therapeutics; Alexion Pharmaceuticals, Inc.; Amgen; Ardelyx; AstraZeneca; AVEO Pharmaceuticals, Inc.; B.Braun; Chugai Pharma USA, LLC; Cytokinetics; Daiichi Sankyo, Inc.; DaVita; Fresenius Medical Care North America (FMC-NA); Genentech, Inc.; GlaxoSmithKline; Haymarket Media; Hospira; Fresenius Kabi; Keryx Biopharmaceuticals; Kissei, Novartis, Novo-Nordisk, OPKO Health; Pfizer; Regulus Therapeutics; Relypsa; Resverlogix; Dr Schaer; Sandoz; Sanofi; Shire; Takeda; Vifor; ZS Pharma
Has the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca,; Bayer; Boehringer Ingelheim; NephroNet; Relypsa
Has the following relevant financial relationships:
Served as an advisor or consultant for: Akebia Therapeutics; Cara Therapeutics; Vifor Pharma
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Otsuka Pharmaceuticals
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Akebia Therapeutics; Ardelyx; AstraZeneca; Aurinia; Chiesi Global Inc.; Chinook Therapeutics; GlaxoSmithKline; Otsuka, Sanofi; Tricida; Vifor; Vifor Fresenius Medical Care Renal Pharma
Served as a speaker or a member of a speakers bureau for: Amgen; AstraZeneca; Aurinia; Bayer; Baxter; Fresenius Medical Care; Genzyme; Janssen; Natera; Vifor
Received grants for clinical research from: Alnylam Pharmaceuticals; AstraZeneca; Bayer; Gilead; GlaxoSmithKline; Idorsia Pharmaceuticals; Kadmon Corporation; Novo Nordisk; Omeros; Palladio Biosciences; Pfizer; Protalix Biotherapeutics; Reata Pharmaceuticals; Regulus Therapeutics; Summit Therapeutics; Sanofi
